Jeffrey Farrow Insider Trades & Stock Holdings

Chief Financial Officer and Chief Strategy Officer · Tarsus Pharmaceuticals, Inc. · Latest filing Jun 16, 2026

Jeffrey Farrow, Chief Financial Officer and Chief Strategy Officer at Tarsus Pharmaceuticals, Inc. has 1 Form 4 trade on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($877.44K), net -$877.44K. Latest filing: disposed of 14.40K shares of $TARS on Jun 16, 2026 at $60.95.

Trades on file

1

Open-market bought

$0

Open-market sold

$877.44K

Net open-market

-$877.44K

Latest filing

Jun 16, 2026

All insider trades by Jeffrey Farrow

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 16, 2026	$TARS	Sell (Open-market sale)	14.40K	$60.95	$877.44K			+8.8%	-5.1%		Chief Financial Officer and Chief Strategy Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Jeffrey Farrow traded

• $TARS

Frequently asked questions

Has Jeffrey Farrow been buying or selling stock?

Jeffrey Farrow has 0 open-market purchases and 1 open-market sale on file, net -$877.44K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Jeffrey Farrow's latest insider trade?

disposed of 14.40K shares of $TARS on Jun 16, 2026 at $60.95.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.